The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: A large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
Open accessAbstract
People with severe mental illness (SMI) – schizophrenia, bipolar disorder and major depressive disorder – appear at risk for cardiovascular disease (CVD), but a comprehensive meta‐analysis is lacking. We conducted a large‐scale meta‐analysis assessing the prevalence and incidence of CVD; coronary heart disease; stroke, transient ischemic attack or cerebrovascular disease; congestive heart failure; peripheral vascular disease; and CVD‐related death in SMI patients (N=3,211,768) versus controls (N=113,383,368) (92 studies). The pooled CVD prevalence in SMI patients (mean age 50 years) was 9.9% (95% CI: 7.4‐13.3). Adjusting for a median of seven confounders, patients had significantly higher odds of CVD versus controls in cross‐sectional studies (odds ratio, OR=1.53, 95% CI: 1.27‐1.83; 11 studies), and higher odds of coronary heart disease (OR=1.51, 95% CI: 1.47‐1.55) and cerebrovascular disease (OR=1.42, 95% CI: 1.21‐1.66). People with major depressive disorder were at increased risk for coronary heart disease, while those with schizophrenia were at increased risk for coronary heart disease, cerebrovascular disease and congestive heart failure. Cumulative CVD incidence in SMI patients was 3.6% (95% CI: 2.7‐5.3) during a median follow‐up of 8.4 years (range 1.8‐30.0). Adjusting for a median of six confounders, SMI patients had significantly higher CVD incidence than controls in longitudinal studies (hazard ratio, HR=1.78, 95% CI: 1.60‐1.98; 31 studies). The incidence was also higher for coronary heart disease (HR=1.54, 95% CI: 1.30‐1.82), cerebrovascular disease (HR=1.64, 95% CI: 1.26‐2.14), congestive heart failure (HR=2.10, 95% CI: 1.64‐2.70), and CVD‐related death (HR=1.85, 95% CI: 1.53‐2.24). People with major depressive disorder, bipolar disorder and schizophrenia were all at increased risk of CVD‐related death versus controls. CVD incidence increased with antipsychotic use (p=0.008), higher body mass index (p=0.008) and higher baseline CVD prevalence (p=0.03) in patients vs. controls. Moreover, CVD prevalence (p=0.007), but not CVD incidence (p=0.21), increased in more recently conducted studies. This large‐scale meta‐analysis confirms that SMI patients have significantly increased risk of CVD and CVD‐related mortality, and that elevated body mass index, antipsychotic use, and CVD screening and management require urgent clinical attention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Schizophrenia is associated with one of the highest risks of premature mortality among psychiatric disorders, with a 15–20 year life expectancy gap [1].”
From Trends in Sudden Death Among Schizophrenia Inpatients (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While causes are multifactorial, cardiometabolic risk factors such as cardiovascular disease and obesity are recognised major contributors [1,2,10,11].”
From A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis. (2022) · cites this paper as [10]
Experimental — accuracy not yet measuredIn the citing paper
“Rates of diabetes and metabolic syndrome are similar to those seen in severe mental illness.14,15”
From The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness (2019) · cites this paper as [14]
In the citing paper
“Pooled T2DM prevalence = 12.4% (95% CI, 11.8-13.9%)”
From The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,586
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,003
Kennedy, K. G., Mio, M., Goldstein, B. I., Brambilla, P., & Delvecchio, G. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.03.040 · Cited by 20
Rehman, M., Chaudhary, R., Rajput, S., Agarwal, V., Kaushik, A. S., Srivastava, S., Srivastava, S., Singh, R., Aziz, I., Singh, S. P., et al. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114207 · Cited by 18
Glasdam, S., Hybholt, L., & Stjernswärd, S. (2023) · Healthcare · doi:10.3390/healthcare11131897 · Cited by 18
Sex-Specific Association Between Genetic Risk of Psychiatric Disorders and Cardiovascular Diseases
Jiang, J.-C., Singh, K., Nitin, R., Davis, L. K., Wray, N. R., & Shah, S. H. (2024) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.124.004685 · Cited by 19
Mortality risk following acute coronary syndrome among patients with schizophrenia: A meta-analysis
Shao, M., Tian, H., Wang, L., Jiang, D., Ji, F., & Zhuo, C. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109737 · Cited by 18
de Caluwé, L., van Buitenen, N., Gelan, P., Crunelle, C., Thomas, R., Casseres, S., Matthys, F., Harten, P., & Cahn, W. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112558 · Cited by 15
Werneck, A. O., Christófaro, D. G. D., Ritti‐Dias, R. M., Cucato, G. G., Stubbs, B., Oyeyemi, A. L., Conceição, R. D. O., Santos, R. D., & Bittencourt, M. S. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112967 · Cited by 19
Self-citationHistory of Serious Mental Illness Is a Predictor of Morbidity and Mortality in Cardiac Surgery
Tyerman, Z. M., Mehaffey, J. H., Hawkins, R. B., Dahl, J. J., Narahari, A. K., Chancellor, W. Z., Yount, K. W., Yarboro, L. T., Teman, N. R., & Ailawadi, G. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.04.118 · Cited by 18
Komnenov, D., Quaal, H. L., & Rossi, N. F. (2020) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00245.2020 · Cited by 17
Neuroticism is positively associated with leptin/adiponectin ratio, leptin and IL-6 in young adults
Syk, M., Isaksson, J., Rasmusson, A. J., Ekselius, L., & Cunningham, J. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-89251-y · Cited by 20
Correll, C. U., Chepke, C., Gionfriddo, P., Parks, J., Foxworth, P. M., Basu, A., Brister, T. S., Brown, D., Clarke, C., & Hassoun, Y. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03685-w · Cited by 19
Self-citationClosing the mortality gap for severe mental illness: Are we going in the right direction?
Siddiqi, N., Doran, T., Prady, S. L., & Taylor, J. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.117.203026 · Cited by 18
İmre, O., Çağlayan, C., & Muştu, M. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091342 · Cited by 17
Ho, M. T. H., Chan, J. K. N., Chiu, W. C. Y., Tsang, L. L. W., Chan, K. S. W., Wong, M. M. C., Wong, H. H., Pang, P. F., & Chang, W. C. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.11.002 · Cited by 19
Psychiatric disorders among hospitalized patients deceased with COVID-19 in Italy
Lega, I., Nisticò, L., Palmieri, L., Caroppo, E., Noce, C. L., Donfrancesco, C., Vanacore, N., Scattoni, M. L., Picardi, A., Gigantesco, A., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100854 · Cited by 17
Chen, P., Tsai, S., Pan, C., Chen, Y.-L., Su, S., Chen, C.-C., & Kuo, C. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674211046891 · Cited by 18
Miola, A., Fornaro, M., Sambataro, F., & Solmi, M. (2021) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2821 · Cited by 18
Self-citationMirza, L., Das‐Munshi, J., Chaturvedi, J., Wu, H., Kraljević, Ž., Searle, T., Shaari, S., Mascio, A., Skiada, N., Roberts, A., et al. (2021) · European Psychiatry · doi:10.1192/j.eurpsy.2021.2255 · Cited by 17
Associated factors of stigma toward people with mental illness among university and school students
Omari, O. A., Khalaf, A., Sabei, S. D. A., Wynaden, D., Ballad, C. A. C., Dameery, K. A., & Qadire, M. I. A. (2021) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12982 · Cited by 17
Kang, D., Lu, J., Liu, W., Shao, P., & Wu, R. (2022) · Schizophrenia · doi:10.1038/s41537-022-00211-5 · Cited by 17
Chen, R., Yang, Z., Liu, J., Cai, X. M., Huo, Y., Zhang, Z., Li, M., Chang, H., & Luo, X. (2022) · Genome Medicine · doi:10.1186/s13073-022-01057-3 · Cited by 20
Drug–drug interactions involving antipsychotics and antihypertensives
Buzea, A., Dima, L., Correll, C. U., & Manu, P. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2086121 · Cited by 17
Self-citationCai, L., Wei, L., Yao, J., Qin, Y., You, Y., Xu, L., Tang, J., & Chen, W. (2022) · General Psychiatry · doi:10.1136/gpsych-2022-100918 · Cited by 17
Rohde, C., Köhler‐Forsberg, O., Nierenberg, A. A., & Østergaard, S. D. (2023) · Bipolar Disorders · doi:10.1111/bdi.13308 · Cited by 17
Curtis, J., Teasdale, S. B., Morell, R., Wadhwa, P., Watkins, A., Lederman, O., O’Donnell, C. A., Fibbins, H., & Ward, P. B. (2024) · Early Intervention in Psychiatry · doi:10.1111/eip.13508 · Cited by 17
Self-citationCardiovascular mortality in bipolar disorder: Population‐based cohort study
Paljärvi, T., Herttua, K., Taipale, H. T., Lähteenvuo, M., Tanskanen, A., & Tiihonen, J. (2024) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13715 · Cited by 19
Vancampfort, D., Probst, M., Basangwa, D., Binder, M. D., Myin‐Germeys, I., van Winkel, R., Ward, P. B., Rosenbaum, S., & Mugisha, J. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.11.067 · Cited by 17
Self-citationHerbsleb, M., Schumann, A., Malchow, B., Puta, C., Schulze, P. C., Gabriel, H. W., & Bär, K. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.020 · Cited by 20
Exercise effects on cognitive functioning in young adults with first-episode psychosis: FitForLife
Hallgren, M. Å., Skott, M., Ekblom, Ö. B., Firth, J., Schembri, A. J., & Forsell, Y. (2018) · Psychological Medicine · doi:10.1017/s0033291718001022 · Cited by 17
Costa, R., Teasdale, S. B., Abreu, S., Bastos, T. C. L., Probst, M., Rosenbaum, S., Ward, P. B., & Corredeira, R. (2019) · Issues in Mental Health Nursing · doi:10.1080/01612840.2019.1642426 · Cited by 17
Self-citationBrowne, J., Battaglini, C. L., Jarskog, L. F., Sheeran, P., Abrantes, A. M., McDermott, J., Elliott, T., González, O., & Penn, D. L. (2021) · Mental health and physical activity · doi:10.1016/j.mhpa.2021.100393 · Cited by 22
The lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17
Evaluation of major depression symptom networks using clinician-rated and patient-rated data
Feiten, J. G., Mosqueiro, B. P., Uequed, M., Passos, I. C., Fleck, M. P. D. A., & Caldieraro, M. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.102 · Cited by 18
A comprehensive cardiovascular disease risk profile in patients with schizophrenia
Brobakken, M. F., Nygård, M., Taylor, J. L., Güzey, I. C., Morken, G., Reitan, S. K., Heggelund, J., Vedul‐Kjelsås, E., & Wang, E. (2019) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13371 · Cited by 17
Horská, K., Kotolová, H., Karpíšek, M., Babinská, Z., Hammer, T., Procházka, J. H., Štark, T., Micale, V., & Kučerová, J. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115214 · Cited by 17
Climate “Psychopathology”: The Intersection of Mental and Physical Health in the Climate Emergency
Thompson, H. E. (2021) · European Psychologist · doi:10.1027/1016-9040/a000433 · Cited by 15
Happell, B., Waks, S., Bocking, J., Horgan, A. M., Manning, F., Greaney, S., Goodwin, J., Scholz, B., van der Vaart, K. J., Allon, J., et al. (2019) · Journal of Mental Health · doi:10.1080/09638237.2019.1677872 · Cited by 16
Borgmann, M., Ivanda, M., Hadizamani, Y., Mohaupt, M. G., Bals, R., Lucas, R., Hamacher, J., & Köllner, V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232587 · Cited by 18
Pathogenesis and management of Brugada syndrome in schizophrenia: A scoping review
Rastogi, A., Walsh, D. V., Akbari, S., Gall, N. P., Gaughran, F., & Lally, J. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.09.003 · Cited by 16
Self-citationFleetwood, K., Wild, S. H., Smıth, D. J., Mercer, S. W., Licence, K. A. M., Sudlow, C. L. M., & Jackson, C. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.120 · Cited by 18
Implementing prescribing safety indicators in prisons: A mixed methods study
Abuzour, A. S., Magola, E., Dunlop, J., O'Brien, A., Khawagi, W. Y., Ashcroft, D. M., Brown, P., & Keers, R. N. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15107 · Cited by 17
Couttas, T. A., Jieu, B., Rohleder, C., & Leweke, F. M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.885904 · Cited by 17
Exposure to psychotropic medications and mortality in schizophrenia: a 5-year national cohort study
Lin, J.-Y., Yeh, L., & Pan, Y. (2022) · Psychological Medicine · doi:10.1017/s0033291722002732 · Cited by 18
A rationale for considering heart/brain axis control in neuropsychiatric disease
Garrett, L., Trümbach, D., Spielmann, N., Wurst, W., Fuchs, H., Gailus‐Durner, V., de Angelis, M. H., & Hölter, S. M. (2022) · Mammalian Genome · doi:10.1007/s00335-022-09974-9 · Cited by 18
Heart failure and depression: A perspective from bibliometric analysis
Lam, M. I., Chen, P., Xie, X., Lok, K.-I., Liu, Y.-F., Si, T. L., Ungvari, G. S., Ng, C. H., & Xiang, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1086638 · Cited by 17
Browne, J., Battaglini, C. L., Jarskog, L. F., Sheeran, P., Abrantes, A. M., Elliott, T., González, O., & Penn, D. L. (2023) · Mental health and physical activity · doi:10.1016/j.mhpa.2023.100515 · Cited by 20
Salehi, N., Afrashteh, M. Y., Majzoobi, M. R., Ziapour, A., Janjani, P., & Karami, S. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04083-x · Cited by 17
Tien, Y.-T., Wang, L., Lee, Y., Lin, P., Hung, C., Chong, M., & Huang, Y. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.10.023 · Cited by 16
Liu, F., Meng, Y., Wang, R., Shen, S., Li, P., & He, F. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.159 · Cited by 15
Teixeira, A. L., Almeida, O. P., Lavín, P., Barbosa, I. G., Alda, M., Altınbaş, K., Balanzá‐Martínez, V., Briggs, F. B. S., Calkin, C. V., Chen, P., et al. (2024) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2024.06.004 · Cited by 16
Lally, J., Loughlin, A. O., Stubbs, B., Guérandel, A., O'Shea, D. B., & Gaughran, F. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1445968 · Cited by 18
Self-citationExercise and mental health: a complex and challenging relationship
Cooney, G. M. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30291-8 · Cited by 16
Sheikh, M. A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.085 · Cited by 16
Mishu, M. P., Uphoff, E., Aslam, F., Philip, S., Wright, J. M., Tirbhowan, N., Ajjan, R., Azdi, Z. A., Stubbs, B., Churchill, R. C., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013281.pub2 · Cited by 18
Self-citationWerneck, A. O., Schuch, F. B., Stubbs, B., Oyeyemi, A. L., Szwarcwald, C. L., Vancampfort, D., & da Silva, D. R. P. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1073 · Cited by 15
Self-citationManagement of Cardiovascular Health in People with Severe Mental Disorders
Lemogne, C., Blacher, J., Airagnes, G., Hoertel, N., Czernichow, S., Danchin, N., Meneton, P., Limosin, F., & Fiedorowicz, J. G. (2021) · Current Cardiology Reports · doi:10.1007/s11886-020-01436-5 · Cited by 17
Zhong, Y., Hu, M., Wang, Q., Yang, Z.-D., Zhu, N., Wang, F., Zhang, X.-Y., Zhang, C.-F., Min, J., Wang, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81653-2 · Cited by 14
Depression in disabling medical conditions – current perspectives
Senra, H., & McPherson, S. (2021) · International Review of Psychiatry · doi:10.1080/09540261.2021.1887823 · Cited by 14
Biological Mechanism(s) Underpinning the Association between Antipsychotic Drugs and Weight Gain
Panizzutti, B., Bortolasci, C. C., Spolding, B., Kidnapillai, S., Connor, T., Richardson, M. F., Truong, T. T. T., Liu, Z. S.-J., Gray, L. J., Kim, J. H., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184095 · Cited by 16
Carpio, E. M., Ashworth, M. J., Asgari, E., Shaw, C., Schartau, P., Durbaba, S., Nitsch, D., & Molokhia, M. (2021) · Journal of Nephrology · doi:10.1007/s40620-021-01149-0 · Cited by 16
Korge, J., & Nunan, D. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.11.030 · Cited by 16
Ruppert, J., Hartung, D., Westhoff‐Bleck, M., Herrmann, J., Stubbs, B., Cordes, J., Krüger, T. H. C., Lichtinghagen, R., & Kahl, K. G. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0858-y · Cited by 16
Self-citationKerling, A., Hartung, D., Stubbs, B., Kück, M., Tegtbur, U., Grams, L., Weber-Spickschen, T. S., & Kahl, K. G. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s167786 · Cited by 16
Self-citationConstantinides, C., Han, L. K. M., Alloza, C., Antonucci, L. A., Arango, C., Ayesa‐Arriola, R., Banaj, N., Bertolino, A., Borgwardt, S., Bruggemann, J. M., et al. (2022) · medRxiv · doi:10.1101/2022.01.10.21267840 · Cited by 17
Singh, A., Riaz, R., Verma, A., Irfan, H., Shaukat, A. F., Nadeem, A., Goyal, P., Habib, A., & Satapathy, P. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003391 · Cited by 16
Huang, X., Chen, Z., Xu, Z. N., Liu, X., Lv, Y., & Yu, L. (2025) · Brain Sciences · doi:10.3390/brainsci15080875 · Cited by 20
Systematic Quality Improvement and Metabolic Monitoring for Individuals Taking Antipsychotic Drugs
Soda, T., Richards, J., Gaynes, B. N., Cueva, M., Laux, J. P., McClain, C., Frische, R. M., Lindquist, L. K., Cuddeback, G. S., & Jarskog, L. F. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000155 · Cited by 19
Safety profile of clozapine: Analysis using national registry data in Japan
Imazu, S., Hata, T., Toyoda, K., Kubo, Y., Yamauchi, S., Kinoshita, S., Nishihara, M., Inada, K., & Kanazawa, T. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.06.041 · Cited by 16
Sharp, A. L., Pallegadda, R., Baecker, A. S., Park, S., Nassery, N., Hassoon, A., Peterson, S., Pitts, S. I., Wang, Z., Zhu, Y., et al. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.08.016 · Cited by 15
Correll, C. U., Tocco, M., Hsu, J., GOLDMAN, R. S., & Pikalov, A. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.11 · Cited by 15
Self-citationMishu, M. P., Peckham, E. J., Wright, J. M., Taylor, J., Tirbhowan, N., Ajjan, R., Azdi, Z. A., Stubbs, B., Churchill, R. C., & Siddiqi, N. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013281 · Cited by 15
Self-citationMachaczek, K. K., Quirk, H., Firth, J., Carney, R., Copeland, R. J., Pollard, N., Peckham, E. J., Hampshaw, S. M., Haye, S. D.-L., Burton, H., et al. (2022) · Mental health and physical activity · doi:10.1016/j.mhpa.2022.100480 · Cited by 16
Martinuzzi, L. J., Strassnig, M., Depp, C. A., Moore, R. C., Ackerman, R. A., Pinkham, A. E., & Harvey, P. D. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.11.019 · Cited by 15
Coello, K., Forman, J. L., Pedersen, H. H., Vinberg, M., Poulsen, H. E., & Kessing, L. V. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.12.011 · Cited by 15
Predicting future depressive episodes from resting-state fMRI with generative embedding
Galioulline, H., Frässle, S., Harrison, S. J., Pereira, I., Heinzle, J., & Stephan, K. E. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.119986 · Cited by 17
The prevalence and factors associated with mental disorders in a community setting in central Uganda
Akena, D. H., Kiguba, R., Muwhezi, W. W., Kwesiga, B., Kigozi, G., Lukwata, H., & Nakasujja, N. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285091 · Cited by 16
Integrated Care Models for Older Adults with Depression and Physical Comorbidity: A Scoping Review
Tops, L., Beerten, S. G., Vandenbulcke, M., Vermandere, M., & Deschodt, M. (2024) · International Journal of Integrated Care · doi:10.5334/ijic.7576 · Cited by 20
Shen, J., & Jiang, C. (2024) · Schizophrenia · doi:10.1038/s41537-024-00533-6 · Cited by 15
Yarborough, B. J. H., Stumbo, S. P., Cavese, J. A., Yarborough, M. T., & Green, C. A. (2018) · Patient Education and Counseling · doi:10.1016/j.pec.2018.08.036 · Cited by 14
Garriga, M., Wium‐Andersen, M. K., Wium‐Andersen, I. K., Nordentoft, M., & Osler, M. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2019.08.015 · Cited by 15
The Policy Ecology of Behavioral Health Homes: Case Study of Maryland’s Medicaid Health Home Program
Stone, E. M., Daumit, G. L., Kennedy‐Hendricks, A., & McGinty, E. E. (2019) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-019-00973-8 · Cited by 15
Wedervang‐Resell, K., Friis, S., Lonning, V., Smelror, R. E., Johannessen, C. H., Agartz, I., Ulven, S. M., Holven, K. B., Andreassen, O. A., & Myhre, A. M. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.039 · Cited by 15
Guan, S., Fang, X., Gu, X., Zhang, Z., Tang, Z., Wu, X., Liu, H., & Wang, C. (2020) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2020.1790584 · Cited by 15
Barboza, A. B. C., Cabello-Arreola, A., Winham, S. J., Colby, C. L., Romo‐Nava, F., Núñez, N. A., Morgan, R. J., Gupta, R., Bublitz, J. T., Prieto, M. L., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.121 · Cited by 19
“Novel Psychopharmacology for Depressive Disorders”
Fornaro, M., Berardis, D. D., Anastasia, A., & Fusco, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_22 · Cited by 15
Self-citationStroke care and case fatality in people with and without schizophrenia: a retrospective cohort study
Kapral, M. K., Kurdyak, P. A., Casaubon, L. K., Fang, J., Porter, J., & Sheehan, K. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044766 · Cited by 15
Akena, D. H., Kiguba, R., Muhwezi, W. W., Kwesiga, B., Kigozi, G., Nakasujja, N., & Lukwata, H. (2021) · Trials · doi:10.1186/s13063-021-05391-6 · Cited by 15
Pochiero, I., Calisti, F., Comandini, A., Vecchio, A. D., Costamagna, I., Rosignoli, M. T., Cattaneo, A., Nunna, S., Peduto, I., Heiman, F., et al. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s320611 · Cited by 15
Self-citationTorres, N. G., Ruíz-Veguilla, M., Alameda, L., Canal‐Rivero, M., Ruiz, M. J., Gómez‐Revuelta, M., Ayesa‐Arriola, R., Rubio-García, A., Crespo‐Facorro, B., & Vázquez-Bourgón, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.07.007 · Cited by 15
Cardiovascular disease lifestyle risk factors in people with psychosis: a cross-sectional study
Mucheru, D., Hanlon, M., Campbell, L., McEvoy, M., & MacDonald‐Wicks, L. K. (2018) · BMC Public Health · doi:10.1186/s12889-018-5649-5 · Cited by 15
Francillette, Y., Bouchard, B., Boucher, E., Gaboury, S., Bernard, P., Romain, A. J., & Bouchard, K. (2018) · International Conference on PErvasive Technologies Related to Assistive Environments (PETRA) · doi:10.1145/3197768.3201521 · Cited by 15
Ehrbar, J., Brand, S., Colledge, F., Donath, L., Egger, S., Hatzinger, M., Holsboer‐Trachsler, E., Imboden, C., Schweinfurth, N., Vetter, S., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00322 · Cited by 15
Taub, S., Hoshen, M., Balicer, R. D., Kamhi-Nesher, S., Weizman, A., & Krivoy, A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.09.002 · Cited by 15
Cui, Y., Huang, C. X., Gong, Q., Guo, F. H., Li, W., Zhang, L., Cai, X., & Wang, Y. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s309949 · Cited by 15
Comparison of disease burden of major depressive disorder in China and globally from 1991 to 2021
Wang, L., Li, L., Zhang, R., Zhao, J., Wei, M., & Nie, Z. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119816 · Cited by 14
Tavares, V. D. D. O., Vancampfort, D., Hallgren, M. Å., Heißel, A., Chaparro, C. G. A. P., Solmi, M., Tempest, G. D., Neto, L. D. O., Coelho, N. L. G., Firth, J., et al. (2021) · Physiotherapy Research International · doi:10.1002/pri.1904 · Cited by 14
Self-citationFoiselle, M., Barbosa, S., Godin, O., Wu, C., Boukouaci, W., André, M., Aouizerate, B., Berna, F. S., Barau, C., Capdevielle, D., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100436 · Cited by 14
Stȩpień-Wyrobiec, O., Nowak, M., Wyrobiec, G., Morawiec, E., Wierzbik-Strońska, M., Staszkiewicz, R., & Grabarek, B. O. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1025414 · Cited by 20
Adepoju, O. E., Liaw, W. R., Patel, N. C., Rastegar, J. S., Ruble, M. W., Franklin, S. M., Renda, A. M., Obasi, E. M., & Woodard, L. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.39855 · Cited by 15
Micheli, A. D., Provenzani, U., Solmi, M., van Pabst, A. E. V. L., Youssef, E., McGuire, P. K., & Fusar‐Poli, P. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.02.008 · Cited by 15
Self-citation
Metadata
- Authors
- Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., Thapa‐Chhetri, N., Fornaro, M., Gallicchio, D., Collantoni, E., Pigato, G., Favaro, A., Monaco, F., Kohler, C., Vancampfort, D., Ward, P. B., Gaughran, F., Carvalho, A. F., & Stubbs, B.
- Affiliations
- Albert Einstein College of Medicine (US)
- University of Padua (IT)
- UConn Health (US)
- Columbia University (US)
- Department of Clinical Medicine and Translational Psychiatry Research Group Federal University of Ceará Fortaleza Brazil
- KU Leuven (BE)
- UNSW Sydney (AU)
- South London and Maudsley NHS Foundation Trust (GB)
- Institute for Clinical Research and Education in Medicine Padua Italy
- ORCID
- Venue
- World Psychiatry
- Publisher
- Wiley
- Published
- 2017-05-12
- Volume
- 16
- Issue
- 2
- Pages
- 163-180
- ISSN
- 1723-8617 (ISSN-L)
- 2051-5545
- PMC
- PMC5428179
- OpenAlex
- W2613459819
- Semantic Scholar
- fb5e3b86e3edce30541c2d8ac7cce8984059dd54
- Cited by
- 1,729
- References
- 137
- Citations by year
- 2026: 176 · 2025: 223 · 2024: 210 · 2023: 196 · 2022: 210 · 2021: 232 · 2020: 185 · 2019: 153 · 2018: 109 · 2017: 32
- FWCI
- 101.38
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-01-19)
- Open access
- bronze
- doi.org
- Locations
- World Psychiatry (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Lirias (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Stanley Medical Research Institute
- King's College Hospital NHS Foundation Trust
- National Institute for Health and Care Research
- King's College London
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- cardiovascular disease, severe mental illness, schizophrenia, bipolar disorder, major depressive disorder, coronary artery disease, cerebrovascular disease, stroke, congestive heart failure, peripheral vascular disease, cardiovascular mortality, CVD risk factors, comorbidities, cardiovascular risk stratification, cardiovascular disease prevention, cardiac rehabilitation, cardiovascular education
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review